clarithromycin

clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.

Cross Reference

Introduction

To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with clarithromycin?

clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with clarithromycin

MeSH term MeSH ID Detail
Bacterial Infections D001424 21 associated lipids
Pain D010146 64 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Stomach Diseases D013272 7 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Skin Neoplasms D012878 12 associated lipids
Colitis D003092 69 associated lipids
Leishmaniasis, Visceral D007898 13 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Per page 10 20 50 100 | Total 242

PubChem Associated disorders and diseases

What pathways are associated with clarithromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with clarithromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with clarithromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with clarithromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with clarithromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with clarithromycin?

Mouse Model

Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).

Knock-out

Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).

Experimental Pneumococcal Meningitis

Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with clarithromycin

Download all related citations
Per page 10 20 50 100 | Total 7636
Authors Title Published Journal PubMed Link
Walkey AJ and Wiener RS Macrolide antibiotics and survival in patients with acute lung injury. 2012 Chest pmid:22116799
Choi HS et al. Comparison of sequential and 7-, 10-, 14-d triple therapy for Helicobacter pylori infection. 2012 World J. Gastroenterol. pmid:22654429
Majima Y et al. Efficacy of combined treatment with S-carboxymethylcysteine (carbocisteine) and clarithromycin in chronic rhinosinusitis patients without nasal polyp or with small nasal polyp. 2012 Auris Nasus Larynx pmid:21636230
Shakya N et al. Discovery of novel 5-(ethyl or hydroxymethyl) analogs of 2'-'up' fluoro (or hydroxyl) pyrimidine nucleosides as a new class of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium avium inhibitors. 2012 Bioorg. Med. Chem. pmid:22664188
Milani M et al. The status of antimicrobial resistance of Helicobacter pylori in Eastern Azerbaijan, Iran: comparative study according to demographics. 2012 J. Infect. Chemother. pmid:22581031
Perić A et al. Effect of long-term, low-dose clarithromycin on T helper 2 cytokines, eosinophilic cationic protein and the 'regulated on activation, normal T cell expressed and secreted' chemokine in the nasal secretions of patients with nasal polyposis. 2012 J Laryngol Otol pmid:22559798
Hiramatsu M et al. Risk factors that affect the surgical outcome in the management of focal bronchiectasis in a developed country. 2012 Ann. Thorac. Surg. pmid:22119119
Zarogoulidis P et al. Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases. 2012 Eur. J. Clin. Pharmacol. pmid:22105373
Bondon-Guitton E et al. Drug-induced gingival overgrowth: a study in the French Pharmacovigilance Database. 2012 J. Clin. Periodontol. pmid:22519416
Bosnar M et al. N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity. 2012 J. Med. Chem. pmid:22697905
Bai J et al. Erythromycin enhances CD4+Foxp3+ regulatory T-cell responses in a rat model of smoke-induced lung inflammation. 2012 Mediators Inflamm. pmid:22701274
Park HG et al. Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients. 2012 Aliment. Pharmacol. Ther. pmid:22066530
Chung JW et al. Resistance of Helicobacter pylori strains to antibiotics in Korea with a focus on fluoroquinolone resistance. 2012 J. Gastroenterol. Hepatol. pmid:21793912
Malfertheiner P et al. Helicobacter pylori: clinical management. 2012 Curr. Opin. Gastroenterol. pmid:23010682
Tepes B et al. Treatment of Helicobacter pylori infection 2012. 2012 Helicobacter pmid:22958154
Al Aukidy M et al. Monitoring release of pharmaceutical compounds: occurrence and environmental risk assessment of two WWTP effluents and their receiving bodies in the Po Valley, Italy. 2012 Sci. Total Environ. pmid:22967493
Sarker SA et al. Influence of Helicobacter pylori infection on gastric acid secretion in pre-school Bangladeshi children. 2012 Helicobacter pmid:22967116
Nishizawa T et al. Proton pump inhibitor-amoxicillin-clarithromycin versus proton pump inhibitor-amoxicillin-metronidazole as first-line Helicobacter pylori eradication therapy. 2012 J Clin Biochem Nutr pmid:22962528
Amin M et al. Green synthesis of silver nanoparticles through reduction with Solanum xanthocarpum L. berry extract: characterization, antimicrobial and urease inhibitory activities against Helicobacter pylori. 2012 Int J Mol Sci pmid:22949839
Spyridaki A et al. Effect of clarithromycin in inflammatory markers of patients with ventilator-associated pneumonia and sepsis caused by Gram-negative bacteria: results from a randomized clinical study. 2012 Antimicrob. Agents Chemother. pmid:22564837
Cajigas-Pezo D et al. [Swelling of right knee in an immunologically compromised patient]. 2012 Enferm. Infecc. Microbiol. Clin. pmid:22521279
McCallum GB et al. Antibiotics for persistent cough or wheeze following acute bronchiolitis in children. 2012 Cochrane Database Syst Rev pmid:23235681
Aguilar JA et al. Decoupling two-dimensional NMR spectroscopy in both dimensions: pure shift NOESY and COSY. 2012 Angew. Chem. Int. Ed. Engl. pmid:22588724
Yoon JH et al. Trends in the eradication rates of Helicobacter pylori infection for eleven years. 2012 World J. Gastroenterol. pmid:23236238
Al-Abri SS et al. An audit of inpatient management of community-acquired pneumonia in Oman: a comparison with regional clinical guidelines. 2012 J Infect Public Health pmid:22632599
Girgis DO et al. Ocular infections caused by non-tuberculous mycobacteria: update on epidemiology and management. 2012 Clin. Experiment. Ophthalmol. pmid:21902780
Kurinčič M et al. Epigallocatechin gallate as a modulator of Campylobacter resistance to macrolide antibiotics. 2012 Int. J. Antimicrob. Agents pmid:22999765
Kudo T et al. Comparison of lafutidine and rabeprazole in 7-day second-line amoxicillin- and metronidazole-containing triple therapy for Helicobacter pylori: a pilot study. 2012 Helicobacter pmid:22759327
Roccarina D et al. Different Antibiotic No Culture Eradicating (DANCE) strategy: an easy way to manage H. pylori eradication. 2012 Dig Liver Dis pmid:22743557
Tursi A et al. Efficacy and tolerability of a third-line, levofloxacin-based, 10-day sequential therapy in curing resistant Helicobacter pylori infection. 2012 J Gastrointestin Liver Dis pmid:22720300
Giguère S et al. In vitro synergy, pharmacodynamics, and postantibiotic effect of 11 antimicrobial agents against Rhodococcus equi. 2012 Vet. Microbiol. pmid:22704561
Kumar KV et al. Recurrent insulin injection abscesses: Atypical etiology. 2012 Indian J Endocrinol Metab pmid:22701833
Kim BJ et al. Discovery of a novel hsp65 genotype within Mycobacterium massiliense associated with the rough colony morphology. 2012 PLoS ONE pmid:22693637
Szałek E et al. Sunitinib in combination with clarithromycin or azithromycin - is there a risk of interaction or not? 2012 Pharmacol Rep pmid:23406766
Brereton AS and El Teraifi H Mycobacterium malmoense: dissemination causes a popliteal aneurysm in a 74-year-old man. 2012 BMJ Case Rep pmid:22602841
Jigorel E and Houston JB Utility of drug depletion-time profiles in isolated hepatocytes for accessing hepatic uptake clearance: identifying rate-limiting steps and role of passive processes. 2012 Drug Metab. Dispos. pmid:22593038
Slater CM and Ford AC Treatment of Helicobacter pylori in Latin America. 2012 Lancet pmid:22305216
Timour Q et al. Sudden death of cardiac origin and psychotropic drugs. 2012 Front Pharmacol pmid:22590457
Gatta L et al. Treatment of Helicobacter pylori in Latin America. 2012 Lancet pmid:22305217
Dicicco M et al. Efficacy of clarithromycin on biofilm formation of methicillin-resistant Staphylococcus pseudintermedius. 2012 BMC Vet. Res. pmid:23171620
Graham DY and Trespalacios AA Treatment of Helicobacter pylori in Latin America. 2012 Lancet pmid:22305218
Noguchi S et al. Clarithromycin form I determined by synchrotron X-ray powder diffraction. 2012 Acta Crystallogr C pmid:22307251
Soares DN et al. Cross-sectional microhardness of bovine enamel subjected to three paediatric liquid oral medicines: an in vitro study. 2012 Eur Arch Paediatr Dent pmid:23043884
Loghmari H et al. Clarithromycin versus metronidazole in first-line Helicobacter pylori eradication. Prospective randomized study of 85 Tunisian adults. 2012 Tunis Med pmid:22311445
Shiota S et al. Association of helicobacter pylori dupA with the failure of primary eradication. 2012 J. Clin. Gastroenterol. pmid:22298090
Bayles T et al. Clarithromycin for community-acquired pneumonia: beware drug interactions. 2012 Intern Med J pmid:23046194
Liang JH et al. Structure-activity relationships of novel alkylides: 3-O-arylalkyl clarithromycin derivatives with improved antibacterial activities. 2012 Eur J Med Chem pmid:22301216
Conde-Álvarez R et al. The lipopolysaccharide core of Brucella abortus acts as a shield against innate immunity recognition. 2012 PLoS Pathog. pmid:22589715
Lee RP et al. Mycobacterium chelonae infection after total knee arthroplasty: a case report. 2012 J Orthop Surg (Hong Kong) pmid:22535831
Shaaban HS et al. Mycobacterium chelonae infection of the parotid gland. 2012 J Glob Infect Dis pmid:22529633
Farivar TN et al. Assessment of helicobacter pylori prevalence by scorpion real-time PCR in chronic tonsillitis patients. 2012 J Glob Infect Dis pmid:22529626
Zheng Q et al. Occurrence and distribution of antibiotics in the Beibu Gulf, China: impacts of river discharge and aquaculture activities. 2012 Mar. Environ. Res. pmid:22525825
Misiewicz JJ Management of Helicobacter pylori-related disorders. 2012 Eur J Gastroenterol Hepatol pmid:22498902
Senhorinho GN et al. Occurrence and antimicrobial susceptibility of Porphyromonas spp. and Fusobacterium spp. in dogs with and without periodontitis. 2012 Anaerobe pmid:22609780
Lee HY et al. Survey of methadone-drug interactions among patients of methadone maintenance treatment program in Taiwan. 2012 Subst Abuse Treat Prev Policy pmid:22429858
Lin Z and Will Y Evaluation of drugs with specific organ toxicities in organ-specific cell lines. 2012 Toxicol. Sci. pmid:22166485
Onoe H et al. Buruli ulcer accompanied by pain in a Japanese patient. 2012 J. Dermatol. pmid:22168180
Peters J et al. Clarithromycin is absorbed by an intestinal uptake mechanism that is sensitive to major inhibition by rifampicin: results of a short-term drug interaction study in foals. 2012 Drug Metab. Dispos. pmid:22170330
Li Y et al. Detection of clarithromycin resistance in Helicobacter pylori following noncryogenic storage of rapid urease tests for 30 days. 2012 J Dig Dis pmid:22188917
Mochizuki Y et al. Chronic mandibular osteomyelitis with suspected underlying synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome: a case report. 2012 J Inflamm Res pmid:22427727
Chang CS et al. Synthesis and bioevaluation of novel 3,4,5-trimethoxybenzylbenzimidazole derivatives that inhibit Helicobacter pylori-induced pathogenesis in human gastric epithelial cells. 2012 Eur J Med Chem pmid:22217866
Farfan-Portet MI et al. Patient socioeconomic determinants of the choice of generic versus brand name drugs in the context of a reference price system: evidence from Belgian prescription data. 2012 Eur J Health Econ pmid:22427042
Kargar M et al. Real-time PCR for Helicobacter pylori quantification and detection of clarithromycin resistance in gastric tissue from patients with gastrointestinal disorders. 2012 Res. Microbiol. pmid:22177975
Mégraud F The challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapy. 2012 Therap Adv Gastroenterol pmid:22423259
Guillot S et al. Macrolide-resistant Bordetella pertussis infection in newborn girl, France. 2012 Emerging Infect. Dis. pmid:22608348
Brown-Elliott BA et al. Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. 2012 Clin. Microbiol. Rev. pmid:22763637
Butler CC et al. Effectiveness of multifaceted educational programme to reduce antibiotic dispensing in primary care: practice based randomised controlled trial. 2012 BMJ pmid:22302780
Carlos CA et al. Mycobacterial infection identified with broad-range PCR amplification and suspension array identification. 2012 J. Cutan. Pathol. pmid:22764735
Anand TD et al. Superantigen profiles of emm and emm-like typeable and nontypeable pharyngeal streptococcal isolates of South India. 2012 Ann. Clin. Microbiol. Antimicrob. pmid:22296671
Tonkic A et al. Time trends of primary antibiotic resistance of Helicobacter pylori isolates in Southern Croatia. 2012 J Chemother pmid:22759765
Wang YJ et al. Rapid quantitative analysis of clarithromycin in rat plasma by UPLC-MS/MS after intravenous injection of the clarithromycin-loaded ultrafine PLGA nanoparticles. 2012 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:22483396
Trigo P and Fischer GW Managing atrial fibrillation in the elderly: critical appraisal of dronedarone. 2012 Clin Interv Aging pmid:22291468
Erdur B et al. Comparison of sequential and standard therapy for Helicobacter pylori eradication in children and investigation of clarithromycin resistance. 2012 J. Pediatr. Gastroenterol. Nutr. pmid:22465935
Correia M et al. Docosahexaenoic acid inhibits Helicobacter pylori growth in vitro and mice gastric mucosa colonization. 2012 PLoS ONE pmid:22529974
Altman JK and Platanias LC A new purpose for an old drug: inhibiting autophagy with clarithromycin. 2012 Leuk. Lymphoma pmid:22288786
McNulty CA et al. Is Helicobacter pylori antibiotic resistance surveillance needed and how can it be delivered? 2012 Aliment. Pharmacol. Ther. pmid:22469191
Polat Z et al. Comparison of levofloxacin-containing sequential and standard triple therapies for the eradication of Helicobacter pylori. 2012 Eur. J. Intern. Med. pmid:22284248
Jakopović IP et al. Novel desosamine-modified 14- and 15-membered macrolides without antibacterial activity. 2012 Bioorg. Med. Chem. Lett. pmid:22503348
Lopes R et al. [Antibiomania: a case of a manic episode induced by clarithromycin]. 2011 Sep-Oct Acta Med Port pmid:22525636
Yasar KK et al. Successfully treated Mycobacterium abscessus mastitis: a rare cause of breast masses. 2011 Oct-Dec Indian J Med Microbiol pmid:22120809
Eisig JN et al. Helicobacter pylori antibiotic resistance in Brazil: clarithromycin is still a good option. 2011 Oct-Dec Arq Gastroenterol pmid:22147131
Abadi AT et al. High frequency of A2143G mutation in clarithromycin-resistant Helicobacter pylori isolates recovered from dyspeptic patients in Iran. 2011 Nov-Dec Saudi J Gastroenterol pmid:22064338
Bilgili SG et al. Phototoxic dermatitis due to Chenopodium album in a child. 2011 Nov-Dec Pediatr Dermatol pmid:21854411
Lee CY et al. Digoxin toxicity precipitated by clarithromycin use: case presentation and concise review of the literature. 2011 Nov-Dec Can J Cardiol pmid:21907534
Zeng M et al. Comparison of efficacy of mometasone furoate versus clarithromycin in the treatment of chronic rhinosinusitis without nasal polyps in Chinese adults. 2011 Nov-Dec Am J Rhinol Allergy pmid:22185725
Mello CF and Negra MD Impact of macrolide therapy on mortality of HIV-infected patients with community-acquired pneumonia in a tertiary teaching hospital. 2011 May-Jun Braz J Infect Dis pmid:21670928
Schmidt D [The choice of treatment in HP associated ulcer: metronidazole or amoxicillin--nothing else!]. 2011 May 4-10 Lakartidningen pmid:21809531
Steyaert S et al. Soft tissue infections with atypical mycobacteria in two patients with inflammatory rheumatic diseases using TNF-inhibitors and/or leflunomide. 2011 Mar-Apr Acta Clin Belg pmid:21630616
Söderberg KC and Böttiger Y [Difficult choice between clarithromycin and metronidazole in polyneuropathy]. 2011 Mar 9-15 Lakartidningen pmid:21744557
Chung JW et al. The trends of one-week first-line and second-line eradication therapy for Helicobacter pylori infection in Korea. 2011 Jan-Feb Hepatogastroenterology pmid:21510323
Galmés-Truyols A et al. An outbreak of cutaneous infection due to Mycobacterium abscessus associated to mesotherapy. 2011 Aug-Sep Enferm. Infecc. Microbiol. Clin. pmid:21684045
Tsoupras AB et al. In vitro anti-inflammatory and anti-coagulant effects of antibiotics towards Platelet Activating Factor and thrombin. 2011 J Inflamm (Lond) pmid:21736752
Albrecht P et al. Sequential therapy compared with standard triple therapy for Helicobacter pylori eradication in children: a double-blind, randomized, controlled trial. 2011 J. Pediatr. pmid:21371717
Kharlamb V et al. Oral antibiotic treatment of Helicobacter pylori leads to persistently reduced intestinal colonization rates with Oxalobacter formigenes. 2011 J. Endourol. pmid:22017284
Song KH et al. Healing effects of rebamipide and omeprazole in Helicobacter pylori-positive gastric ulcer patients after eradication therapy: a randomized double-blind, multinational, multi-institutional comparative study. 2011 Digestion pmid:21757914
Cerqueira L et al. PNA-FISH as a new diagnostic method for the determination of clarithromycin resistance of Helicobacter pylori. 2011 BMC Microbiol. pmid:21569555
Malik R et al. Effect of Helicobacter pylori eradication therapy in iron deficiency anaemia of pregnancy - a pilot study. 2011 Indian J. Med. Res. pmid:21911976
Teke T et al. 2009 H1N1 influenza and experience in three critical care units. 2011 Int J Med Sci pmid:21487571
Vahedi M et al. Saliva secretion and efficacy of helicobacter pylori eradication in peptic ulcer patients. 2011 J Dent (Tehran) pmid:22509455
Proudfoot AG et al. Human models of acute lung injury. 2011 Dis Model Mech pmid:21357760